Document is current

Any future updates will be listed below

Correction to: Clinical summary of fibroblast activation protein inhibitor‑based radiopharmaceuticals: cancer and beyond

Crossref DOI link: https://doi.org/10.1007/s00259-022-05823-8

Published Online: 2022-05-06

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark